Adage Capital Partners Gp, L.L.C. Merck & Co., Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,495,561 shares of MRK stock, worth $116 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
1,495,561
Previous 1,492,861
0.18%
Holding current value
$116 Million
Previous $170 Million
12.24%
% of portfolio
0.27%
Previous 0.31%
Shares
30 transactions
Others Institutions Holding MRK
# of Institutions
3,940Shares Held
1.86BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$19.5 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.41 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$4.76 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.44 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $197B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...